 Interpace Biosciences IDXG announced today that its subsidiary, Interpace Diagnostics, has entered into a contract with Avalon Healthcare Solutions Avalon, a specialty benefit management company with more than 3 million members, focused on laboratory testing. The new contract, whose terms were not disclosed, includes two of the Southeastern U.S.s largest Blue Cross Blue Shield plans where members can now take advantage of the benefits of ThyGeNEXT and ThyraMIR thyroid testing while reducing their out of pocket expenses due to Interpaces status as an in-network provider. Interpace has successfully achieved positive medical coverage for its services through Medicare as well as other leading national and regional health plans and is now focused on establishing more contracts to optimize the adjudication process. 